All Articles

Leading life science REIT Alexandria Real Estate slashes its dividend by 45%. Is this a prudent pivot or a warning sign for the entire sector?

Two AI leaders unite to end the 'Revenue Void' with a system that promises to turn uncertain forecasts into a predictable, data-driven growth engine.

Enphase Energy's IQ EV Charger 2 goes beyond charging, integrating solar and future-proofing homes for a new era of energy independence and grid resilience.

Beyond the numbers, CACI's renewed $145M pact with the U.S. Navy is a critical investment in America's submarine readiness. Here's the strategic analysis.

Stem's move to add CEO Arun Narayanan to its board is more than a title change; it's a strategic gambit to accelerate its software-first future.

A new report reveals retirees with guaranteed income are 30% more secure. Is this the key to solving the retirement crisis and ending financial fear?

As Star Group preps its year-end report, the results will offer key insights into winter heating costs and the company's strategy for a changing world.

New data shows a non-invasive light-and-sound therapy may boost brain resilience and slow Alzheimer's, positioning it as a disruptive force in the market.

Beyond the press release, a deep dive into how the Averna-Spherea consolidation is set to redefine quality engineering for mission-critical industries.

Beyond the price surge, a deeper shift is underway. Discover how institutional adoption and artificial intelligence are fundamentally reshaping the crypto landscape.

Voltus's new program pays businesses to cut energy when the grid is dirtiest, creating a novel marketplace where corporate climate goals fund new revenue.

Garrett Motion's $250M share repurchase signals deep financial confidence, but the real story is how it balances shareholder returns with a bold pivot to EV tech.

A struggling shipping firm bets its future on a $120M AI and blockchain venture. Is this a savvy pivot or a desperate move to abandon a sinking ship?

A landmark study reveals only 13% of high-risk heart patients achieve optimal cholesterol control, exposing deep systemic failures and inequities in care.

A new partnership aims to merge AI credit scoring with blockchain to tokenize auto loans, targeting a massive traditional finance market for disruption.

bioAffinity's sputum test provides clarity for ambiguous lung cancer screenings, presenting a powerful economic case for investors and healthcare providers.

A groundbreaking partnership is using AI to save hundreds of lives and slash operational delays, offering a powerful blueprint for data-driven healthcare.

A tiny share sale by investment giant Rathbones reveals subtle strategies and institutional chess moves in the high-stakes takeover battle for Unite Group.

A novel laser treatment for glaucoma is now in human trials, promising to lower eye pressure without a single cut. This could change millions of lives.

A novel class of precision therapy enters human trials, offering a new line of defense for patients with stubborn neuroendocrine tumors and other cancers.